Impact of Ganoderma Lucidum on NRF2 Levels and Antioxidant Status in Metabolic Asscociated Fatty Liver Disease (GL-MAFLD-NRF2 Study)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This RCT investigates the impact of Ganoderma lucidum on antioxidant staus, NRF2 levels and lipid metabolism in individuals with Metabolic Associated Fatty Liver Disease.
Epistemonikos ID: 683f078ee0a369ab452facca91876a2f456fd5c4
First added on: May 05, 2026